| Identification | Back Directory | [Name]
(E)-2-(3,4-dimethoxyphenyl)-4-(pyridin-3-ylmethylene)oxazol-5(4H)-one | [CAS]
304000-05-3 | [Synonyms]
WAY-380496
2-(3,4-Dimethoxyphenyl)-4-(3-pyridinylmethylene)-5(4H)-oxazolone
5(4H)-Oxazolone, 2-(3,4-dimethoxyphenyl)-4-(3-pyridinylmethylene)-
(E)-2-(3,4-dimethoxyphenyl)-4-(pyridin-3-ylmethylene)oxazol-5(4H)-one | [Molecular Formula]
C17H14N2O4 | [MDL Number]
MFCD01917812 | [MOL File]
304000-05-3.mol | [Molecular Weight]
310.3 |
| Chemical Properties | Back Directory | [Boiling point ]
460.9±55.0 °C(Predicted) | [density ]
1.26±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
3.44±0.12(Predicted) | [color ]
Light yellow to yellow |
| Hazard Information | Back Directory | [Uses]
DAPK-IN-2 is a DAPK inhibitor. DAPK-IN-2 can be used for the research of cerebral infarction and ischemic diseases[1]. | [References]
[1] Okamoto M, et al. Structure-activity relationship of novel DAPK inhibitors identified by structure-based virtual screening. Bioorg Med Chem. 2010;18(7):2728-2734. DOI:10.1016/j.bmc.2010.02.018 |
|
|